Accessibility Tools

Prescribing Information & Guidance


Ranibizumab or Bevacizumab for the Treatment of Juxtafoveal Telangiectasia


Bulletin 211- Published Feb 15

Under review – Contact Medicine Optimisation Team at BEDCCG.bedsmeds@nhs.net for details.

Guideline Categories: Ophthalmology

Guideline Areas: Bedfordshire, Luton

Guideline Tags: bevacizumab, juxtafoveal telangiectasia, ranibizumab

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net